Seth Lederman

7PUBLICATIONS
21CO-AUTHORS
Molecular targetsPainInfectious diseasesAnimal protection (incl. pests and pathogens)Computational physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 29, 2026
First-in-Human, Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of TNX-1500, an Fc-Modified anti-CD154 Monoclonal Antibody, Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending Doses in Healthy Adults.

|Jul 08, 2025
Pain relief by targeting nonrestorative sleep in fibromyalgia: a phase 3 randomized trial of bedtime sublingual cyclobenzaprine.

Seth Lederman, Lesley M Arnold, Ben Vaughn

|Aug 29, 2024
High-Throughput Screening Assay for Convalescent Sera in COVID-19: Efficacy, Donor Selection, and Variant Neutralization.

Krishna P Kota, Ilya Trakht, Gavreel Kalantarov

|Apr 22, 2024
Novel factors potentially initiating acute antibody-mediated rejection in pig kidney xenografts despite an efficient immunosuppressive regimen.

Kohei Kinoshita, Akihiro Maenaka, Ivy A Rosales

|Nov 25, 2023
Immunogenicity and Efficacy of TNX-1800, A Live Virus Recombinant Poxvirus Vaccine Candidate, against SARS-CoV-2 Challenge in Nonhuman Primates.

Mayanka Awasthi, Anthony Macaluso, Dawn Myscofski

|Oct 28, 2023
Immunogenicity and Tolerability of a SARS-CoV-2 TNX-1800, a Live Recombinant Poxvirus Vaccine Candidate, in Syrian Hamsters and New Zealand White Rabbits.

Mayanka Awasthi, Anthony Macaluso, Scott J Goebel

Pageof 2

Frequent Collaborators

3 joint publications

Ryan S Noyce

2 joint publications

Mayanka Awasthi

2 joint publications

Gregory M Sullivan

1 joint publications

José Esparza